Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix

Table 1

Clinicopathological characteristics of patients with clear cell carcinoma of the uterine cervix ().

Variables		(%)
Age
<40 years	25	50
≥40 years	25	50
FIGO 2009 stage
IA	2	4
IB	34	68
IIA	12	24
IIB	2	4
Tumour size
<4 cm	33	66
≥4 cm	17	34
Parametrial involvement
Yes	4	8
No	46	92
LVSI
Yes	6	12
No	44	88
Depth of stromal invasion
<1/2	29	58
≥1/2	21	42
Lymph node metastasis
No	45	90
Yes	5	10
Neoadjuvant therapy
Yes	10	20
No	40	80
Adjuvant therapy
Chemotherapy	18	36
Radiotherapy	6	12
Chemoradiotherapy	22	44
None	4	8

FIGO: International Federation of Gynaecology and Obstetrics; LVSI: lymphovascular space invasion.